Monday, December 05, 2016 9:51:22 AM
For me the big enchilada in the room is the Poziotinib abstract (Note - of the 5 presentations this is the only abstract). Why, well we'll see how effective it is in Metastatic BC i.e. the sickest patients where other drug regimes didn't help much. And it will let us know more or less if we have a winner or not. I will go and try to find the abstract later but feel free to post it if you get to it before me.
Regarding SPI-2012/Rolontism (eflapegrastim) the one of special interest for me is the poster on Immunogenicity. I think this would be the only thing that would prevent this drug from being successful; the P2 study really didn't exhibit any concerns but it's good for it to be reinforced. The P3 poster could be of interest too in that it's open label (and randomized) they might decide to give us some feed back on where they are w that one (eg # of pts treated, etc). Essentially though, all the SPI-2012 posters will start prepping the medical world that this drug will be a tool in their arsenal in the not too distant future.
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM